ENETS–ESP Joint Session

Tumour microenvironment in NENs

This joint session with the European Society of Pathology focuses on key components of the tumour microenvironment in neuroendocrine neoplasms. Presentations address the immune landscape and its therapeutic potential, the role of cancer-associated fibroblasts in small bowel NETs, and novel approaches to assessing tumour 3D vasculature. A mini-oral presentation will highlight spatial profiling in highly proliferative lung carcinoids.

Moderators: Jérôme Cros (FRA) and Silvia Uccella (ITA)
Date: Wednesday, 4 March
Time: 09:30–10:30
Room: Theatre Hall (S2)

ENETS–INCA Joint Session

AI and how it relates to the future of NET research and clinical care for patients

This joint session with the International Neuroendocrine Cancer Alliance (INCA) explores the role of artificial intelligence across the full spectrum of neuroendocrine neoplasia research and care. Topics include the use of AI in research and clinical trials, radiomics, clinical decision-making and education, as well as its potential to empower patients and improve access to information and care pathways.

Moderators: Meredith Cummins (AUS) and Rocio Garcia-Carbonero (ESP)
Date: Thursday, 5 March
Time: 16:45–18:15
Room: Theatre Hall (S2)

ENETS–CUT NETS Joint Session

Oligo-progression in metastatic NETs: Observe, cut or medicate?

This joint session with the Collaborative of sUrgical Teams for NeuroEndocrine Tumors (CUTNETs) addresses the clinical challenge of oligo-progression in metastatic neuroendocrine tumours. The session reviews underlying biological mechanisms and discusses the role of systemic therapies, loco-regional approaches and surgery in managing limited disease progression, illustrated through a clinical case presentation and expert discussion.

Moderators: Els Nieveen van Dijkum (NED) and Stefano Partelli (ITA)
Date: Friday, 6 March
Time: 08:00–09:30
Room: Auditorium Hall (S1)

ENETS–EANM Joint Session

Advances in imaging and radioligand therapy in NETs

This joint session with the European Association of Nuclear Medicine focuses on current and emerging approaches in imaging and theranostics for neuroendocrine tumours. Topics include standardised reporting for NET PET, response assessment using SSTR imaging, the current state of SSTR-targeted radioligand therapy, and novel radiopharmaceuticals beyond SSTR targeting. The session also features selected oral and mini-oral presentations on dosimetry-guided therapy and innovative combination approaches.

Moderators: Tessa Brabander (NED) and Andreas Kjær (DEN)
Date: Friday, 6 March
Time: 10:00–11:40
Room: Auditorium Hall (S1)